Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 9/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21707001 | 0.93 | KDM4E (0.38) | KDM4EATML3MBTL1SLC6A2HSD17B10 | |
| SCHEMBL21706999 | 0.92 | KDM4E (0.36) | KDM4EATML3MBTL1SLC6A2 | |
| SCHEMBL21706873 | 0.89 | KDM4E (0.36) | KDM4EATML3MBTL1HSD17B10 | |
| SCHEMBL21706857 | 0.87 | KDM4E (0.40) | KDM4EATML3MBTL1HSD17B10MAPK8 | |
| SCHEMBL21706998 | 0.87 | MEN1 (0.38) | KDM4EATML3MBTL1SLC6A2 | |
| SCHEMBL21699390 | 0.86 | KDM4E (0.41) | KDM4EATML3MBTL1HSD17B10MAPK8 | |
| SCHEMBL21706846 | 0.84 | KDM4E (0.36) | KDM4EATML3MBTL1 | |
| SCHEMBL15730699 | 0.84 | KDM4E (0.50) | KDM4EATML3MBTL1SLC6A2NPY5R | |
| SCHEMBL21699381 | 0.84 | L3MBTL1 (0.37) | KDM4EATML3MBTL1HSD17B10MAPK8 | |
| SCHEMBL21699138 | 0.84 | KDM4E (0.50) | KDM4EATML3MBTL1HSD17B10MAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200052223-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200052223-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | KDM4E 3395/4885ATM 969/4885L3MBTL1 1571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.